Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
VistaJet secures $600m investment from RRJ Capital-led private equity consortium
VistaJet secures $600m investment from RRJ Capital-led private equity consortium VistaJet is set to receive a $600m private equity investment from a consortium led by RRJ Capital, one of Asia’s largest private equity firms. The deal, expected to be finalised in the...
Lone Star, Advent, and Apollo lead bidding for Reckitt’s $6.3bn homecare division
Lone Star, Advent, and Apollo lead bidding for Reckitt’s $6.3bn homecare division Lone Star Funds, Advent International, and Apollo Global Management emerged as the leading contenders to acquire Reckitt Benckiser’s homecare portfolio, as the UK-based consumer goods...
Roark Capital expands restaurant portfolio with $1bn acquisition of Dave’s Hot Chicken
Roark Capital expands restaurant portfolio with $1bn acquisition of Dave’s Hot Chicken Roark Capital struck a $1bn deal to acquire Dave’s Hot Chicken, further cementing its presence in the fast-growing restaurant franchise sector. The Atlanta-based private equity...